Carla Rameri Alexandre Silva de Azevedo

Carla Rameri Alexandre Silva de Azevedo

Auto-generated profile, based on publicly available information

Carla Rameri Alexandre Silva de Azevedo

Instituto de Medicina Integral Professor Fernando Figueira (IMIP), Department of Clinical Oncology, Recife, PE, Brazil

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 August 2021 in Cancer
Verified
Journal Article
Open access
PDF file
GCGuilherme Jorge Costa
Guilherme Jorge Costa
CACarla Rameri Alexandre Silva de Azevedo
Carla Rameri Alexandre Silva de Azevedo
JJJosé Iran Costa Júnior
José Iran Costa Júnior
ABAnke Katharina Bergmann
Anke Katharina Bergmann
LTLuiz Claudio Santos Thuler
Luiz Claudio Santos Thuler
Background: Coronavirus disease 2019 (COVID‐19) and cancer are serious public health problems worldwide. However, little is known about the risk factors of in‐hospital mortality among COVID‐19 patients with and without cancer in Brazil. The objective of this study was to evaluate the risk factors of in‐hospital mortality among COVID‐19 patients with and without cancer and to compare mortality according to gender and topography during the year 2020 in Brazil.Methods: This was a secondary data study of hospitalized adult patients with a diagnosis of COVID‐19 by real‐time polymerase chain reaction testing in Brazil. The data were collected from the Influenza Epidemiological Surveillance Information System.Results: This study analyzed data from 322,817 patients. The prevalence of cancer in patients with COVID‐19 was 2.3%. COVID‐19 patients with neurological diseases and cancer had the most lethal comorbidities in both sexes. COVID‐19 patients with cancer were more likely to be older (median age, 67 vs 62 years; P < .001), to have a longer hospital stay (13.1 vs 11.5 days; P < .001), to be admitted to the intensive care unit (45.3% vs 39.6%; P < .001), to receive more invasive mechanical ventilation (27.1% vs 21.9%), and to have a higher risk of death (adjusted odds ratio [aOR], 1.94; 95% confidence interval [CI], 1.83‐2.06; P < .001) than those without cancer. Patients with hematological neoplasia (aOR, 2.85; 95% CI, 2.41‐3.38; P < .001) had a higher risk of mortality than those with solid tumors (aOR, 1.83; 95% CI, 1.72‐1.95; P < .001) in both sexes.Conclusions: Brazilian COVID‐19 patients with cancer have higher disease severity and a higher risk of mortality than those without cancer.

1 January 2023 in Brazilian Journal of Oncology
Verified
Journal Article
Open access
ACAknar Fc Calabrich
Aknar Fc Calabrich
DADaniele Xavier Assad
Daniele Xavier Assad
GDGraziela Dal-Molin
Graziela Dal-Molin
AMAndreia C. De Melo
Andreia C. De Melo
ARAngelica Nogueira Rodrigues
Angelica Nogueira Rodrigues
FMFernando C Maluf
Fernando C Maluf
To report consensus recommendations on the current role of poly(ADP-ribose) polymerase (PARP) inhibitors in the front-line management of patients with epithelial ovarian cancer (EOC) in the healthcare setting of Brazil. The expert panel convened in March 2021 and comprised 20 medical oncologists focus on gynecological oncology. The panel answered anonymously and based on scientific evidence a total of 67 questions. The panel reached consensus (at least 75% of votes for the same recommendation) or majority vote (50% to 74.9%) for the majority of questions that addressed: (1) who and when to test for BRCA mutations or homologous recombination deficiency (2) what test should be used; (3) when should maintenance PARP inhibitor therapy be indicated; (4) which PARP inhibitor should be used; (5) when should bevacizumab be combined; and (6) toxicity management. The current recommendations may help Brazilian practitioners to improve the use of PARP inhibitors in front-line management of EOC.

11 August 2016
Verified
Conference Paper
Closed access
CACarla Rameri Azevedo
Carla Rameri Azevedo

26 June 2026 in International Journal of Gynecological Cancer
Verified
Journal Article
Closed access
NRNathalia Moreira Ramalho
Nathalia Moreira Ramalho
JSJurema Telles de Oliveira Lima Sales
Jurema Telles de Oliveira Lima Sales
VCVandré Cabral Gomes Carneiro
Vandré Cabral Gomes Carneiro
TBThales Paulo Batista
Thales Paulo Batista
GSGustavo Fonseca de Albuquerque Souza
Gustavo Fonseca de Albuquerque Souza
CACarla Rameri Alexandre Silva de Azevedo
Carla Rameri Alexandre Silva de Azevedo